Speaker

Anna Altieri

Translational Research Associate, Resalis Therapeutics

Anna Altieri, Translational Research Associate, Resalis Therapeutics, is speaking at 2nd Obesity & Weight Loss Drug Development Summit Europe (Munich, Germany, 28–29 Oct 2026) in the session “From Fat Selectivity to Rebound Prevention: Translating RES-010 from Target Discovery to Clinical Development”.

Conferences: 1
Keynotes: 0
Upcoming: 1

Upcoming appearances

2nd Obesity & Weight Loss Drug Development Summit Europe
28–29 Oct 2026Munich, Germany
- SpeakerFrom Fat Selectivity to Rebound Prevention: Translating RES-010 from Target Discovery to Clinical Development

More speakers at 2nd Obesity & Weight Loss Drug Development Summit Europe

Henrik Bjork Hansen
Director - Scientific, Gubra
Steffen-Sebastian Bolz
Executive Board Member and Chief Scientific Officer, APHAIA Pharma AG
Martin Brenner
Chief Executive & Scientific Officer, iBio
Daniel de la Torre
VP of Research & Development, Constructive Bio
Mélanie Flaender
Head of Project Management, Cytoo
Lora Heisler
Professor, University of Aberdeen

See all 19 speakers on the event page

This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by Anna Altieri, and it lists only the talks, sessions and presentations named in those programmes.

Is this you? Claim this profile — every request is read by a person before anything is linked.

To ask for a correction or for this profile to be removed, email [email protected].